Calvin Sandra (CIK 0001882909)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: SVP, CHIEF ACCOUNTING OFFICER
Shares held
6,250
Last filed at
Nov 6, 2025
Confidence Score
12.6
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 16, 2025 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 32.5 -2,910 -5.99% ✓ $104.8K
Nov 4, 2025 Nov 6, 2025 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 5.0 -67,115 -58.03% ✓ $2.4M
Feb 11, 2025 Feb 12, 2025 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 20.0 -54,244 -14.93% ✓ $1.4M
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 95.0 +9,652 17.87% ✗ $67.4K
Jan 22, 2025 Jan 23, 2025 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 46.3 -925 -1.68% ✗ $17.5K
Dec 26, 2024 Dec 27, 2024 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 12.5 -15,000 -21.45% ✓ $258.3K
Nov 25, 2024 Nov 25, 2024 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -12,090 -18.04% ✗ $221.3K
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 91.3 +10,680 25.84% ✗ $24.1K
Jan 23, 2024 Jan 25, 2024 Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Sell 47.5 -910 -2.15% ✗ $8.3K
May 10, 2023 May 12, 2023 Travere Therapeutics, Inc. SVP, Chief Accounting Officer Sell 50.0 -558 -1.30% ✓ $9.2K
Jan 31, 2023 Feb 2, 2023 Travere Therapeutics, Inc. SVP, Chief Accounting Officer Sell 91.3 +7,969 22.88% ✓ $44.4K
Jan 24, 2023 Jan 26, 2023 Travere Therapeutics, Inc. SVP, Chief Accounting Officer Sell 41.3 -1,097 -3.05% ✓ $24K
Sep 13, 2022 Sep 15, 2022 Travere Therapeutics, Inc. SVP, Chief Accounting Officer Sell 50.0 -349 -0.96% ✗ $9.8K
May 10, 2022 May 12, 2022 Travere Therapeutics, Inc. SVP, Chief Accounting Officer Sell 46.3 -881 -2.41% ✗ $19.1K
Jan 31, 2022 Feb 2, 2022 Travere Therapeutics, Inc. VP, Corp Controller and CAO Sell 91.3 +7,952 27.74% ✗ $21.2K
Jan 24, 2022 Jan 26, 2022 Travere Therapeutics, Inc. VP, Corp Controller and CAO Sell 46.3 -934 -3.16% ✗ $23K